Drug recall · October 15, 2025
Doxycycline Hyclate Tablets recall
Why: Failed dissolution specifications: Stability testing found that the lot did not meet dissolution specifications.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Doxycycline Hyclate Tablets, USP 100 mg*, 500-count bottle, Rx Only, Distributed by: Acella Pharmaceuticals, LLC, Alpharetta, GA 30005, NDC 42192-501-05.
- Lots / codes
Lot #: P24ZLK1, Exp 5/31/2027
- Quantity
- 4,680 500-count bottles
- Company
- Acella Pharmaceuticals, LLC, Alpharetta, GA
- Distribution
- Nationwide in the USA
- Initiated
- September 29, 2025 · Voluntary: Firm initiated
- Classified
- October 9, 2025
- Reported
- October 15, 2025
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Doxycycline
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.